Chemical & Life Sciences, Trade Marks
Biotechnology, Chemical, Medical Devices, Nanotechnology, Pharmaceutical
Anton is a Chartered and European patent attorney. He previously worked with other firms of UK patent and trade mark attorneys before joining Venner Shipley LLP in 2008.
Anton specialises in biotechnology-related patent matters, especially those involving molecular biology, bioinformatics, genomics & proteomics, DNA and protein sequences, biochemistry, human genetics, immunology & antibody technology, plant biotechnology, drug delivery, formulations, chemistry, chemical engineering, pharmaceuticals and medicine.
Anton has gained considerable experience in handling all aspects of patent practice. He also has significant experience of advising clients on patent infringement and validity, and providing due diligence opinions. Anton also enjoys complex opposition and appeal work.
Anton works for a broad spectrum of clients, and has extensive experience of working with academic institutions and associated technology transfer departments, university-derived spin-out companies, incubator-based companies, SMEs, as well as large multinational companies. He always strives to provide his clients with clear, commercially relevant advice.
Anton regularly lectures on the patenting of bioscience inventions.
During his career, Anton has also been involved in a wide range of UK & foreign trade mark issues.
Fellow of the Chartered Institute of Patent Attorneys
Member of the European Patent Institute
Anton graduated from Nottingham University with an honours degree in Biochemistry & Genetics. He then attended UMIST where he obtained a Masters degree in Bioreactor Systems & Chemical Engineering, in which his research involved the design and construction of expression vectors for use in S. coelicolor. Anton also holds a PhD in genetic engineering, in which his research focused on the genetics of ethanol tolerance and production in the yeast, S. cerevisiae. He also has a certificate in Bioinformatics from Manchester University.
- The UK-IPO extends the “Mottainai” pilot for the Patent Prosecution Highway
- US patent attorneys sued for copyright infringement
- Venner Shipley is now the preferred IP firm of the Oxbridge Biotech Roundtable (OBR)
- Record number of European patent applications filed in 2011
- Brüstle v Greenpeace – The Patentability of Stem Cells in Europe